Optimizing The Development And Upscaling Of API / HPAPI And Fermentation Projects


Pharmaceutical and biopharmaceutical projects for the development and upscaling of APIs, HPAPIs and intermediates continue to increase in process complexity. In this interview, Dr. Ingo Klement, Director, Global Business Development for Exclusive Synthesis at Evonik, shares some of the key expectations of customers who are reviewing CMOs to support the development and upscaling of their next major project.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online